Anifrolumab Pregnancy Registry
Are you pregnant and diagnosed with Systemic Lupus Erythematosus (SLE)? Have you taken SAPHNELO® (anifrolumab) or any other medications for the treatment of your SLE during pregnancy?
Systemic Lupus Erythematosus is a chronic disease and can be a debilitating condition during pregnancy for the mother and her child.
Help future pregnant women, doctors, and researchers understand the safety of medications in pregnant women with SLE.
I am a patientAre you a healthcare provider who treats pregnant women with Systemic Lupus Erythematosus?
Help us learn more about the safety of using SAPHNELO® (anifrolumab) and other SLE medications used for treatment during pregnancy.
I am a Healthcare Provider
About the Anifrolumab Pregnancy Registry
A pregnancy registry is a study that collects health information from pregnant women who take prescription medications. Information can also be collected on their newborn babies. This information is then compared to women who have not taken medications or have taken medications other than the drug of interest during pregnancy.
The goal of the Anifrolumab Pregnancy Registry is to help doctors, patients, and researchers better understand the safety of SAPHNELO® (anifrolumab) and other medications for the treatment of Systemic Lupus Erythematosus (SLE) during pregnancy. Pregnant women with SLE living in the United States may be eligible to participate. The Registry collects health information on pregnant women and their developing babies up to 1 year of age, from both enrolled pregnant women and healthcare providers involved in their care and/or the care of their babies.
Would you like to participate?
Learn more about the Registry
Alternatively, call the Registry team toll-free at 1-888-337-0045 and leave your name and number (you can call at any time of the day to leave a message, your call will be returned during hours of operation: 8:30am – 5:00pm EST Monday – Friday).
Additional information
Prescribing Guide